- Open Access
Ketorolac- and warfarin-induced renal toxicity: ultrastructural and biochemical study
The Journal of Basic and Applied Zoology volume 80, Article number: 36 (2019)
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drug classes worldwide. Although, these drugs have a potent analgesic and anti-inflammatory effects associated with nephrotoxicity. Factors such as advanced age and comorbidities may contribute to increase the risk of NSAID-related nephrotoxicity. The current study was designed to study the dual effect of non-NSAIDs and anticoagulants on the rat kidney.
Thirty-two adult male albino rats were divided into four groups (n = 8): first, served as the control group which was orally administered with distilled water; second, served as the ketorolac (KT) group which received a daily intramuscular injection of ketorolac tromethamine (3 mg/kg/day); third, served as the warfarin (WR) group which was orally administered with racemic warfarin (0.3 mg/kg/day); and fourth, served as the combined (KT/WR) group which received an oral administration of WR (0.3 mg/kg/day) followed by an intramuscular injection of KT (3 mg/kg/day). After six consecutive days of daily treatment, all animals were sacrificed and their blood and tissue samples were collected.
A significant decrease in serum level of creatinine was observed in WR- and KT/WR-treated groups. However, urea increased significantly in the serum of the combined group, KT/WR. Furthermore, both WR- and KT/WR-treated groups showed a significant increase in malondialdyhed (MDA) level; however, WR treatment induced a significant decrease in reduced glutathione (GSH) level. The total antioxidant capacity (TAC) of rat kidney showed a significant decrease in all treated groups. Electron microscopic investigations of kidney cortex localized variable degrees of focal degeneration, vacuolation, and vascular congestion in KT- and WR-treated groups that are more vigorously attacking the cortical tissues in KT/WR-treated rats.
We can conclude that the combined therapy of anti-inflammatory and anticoagulant drugs must be avoided or at least minimized, particularly in the elderly people, who mostly had other complications, in order to avoid the severe side effects on kidney structure and function.
The most widely used drug classes worldwide are non-steroidal anti-inflammatory drugs (NSAIDs). Recent studies point to NSAIDs as the most effective treatment for reducing moderate or severe pain. The vigorous development of their uses reflects the great clinical need they address to control of pain and fever, the two common manifestations of broad spectrum of diseases (Utzeri & Usai, 2017). Among these drugs, ketorolac tromethamine being a potent NSAID analgesic inhibits the synthesis of prostaglandins and may relate to adverse effects which can be serious, such as gastrointestinal ulcers and bleeding, heart attack, liver toxicity, and kidney disease (Aly, Mahmoud, Hassan, & Fahmy, 2015; Bally et al., 2017; Ilic et al., 2011; Lanas & Chan, 2017; Tomic et al., 2008). There are interactions between NSAIDs and several classes of anti-thrombotic drugs, including WR being under interest. WR represents the most widely prescribed oral anticoagulant and is used by patients with chronic atrial fibrillation, mechanical valves, deep vein thrombosis, and recurrent stroke (Eriksson & Wadelius, 2012; Li et al., 2016; Liu et al., 2012). It was previously reported to induce acute kidney injury (Brodsky et al., 2009; Brodsky et al., 2010; Brodsky et al., 2011; Ozcan et al., 2012). Many patients, elderly in particular, are highly sensitive to WR and require very low doses to achieve and maintain anticoagulation (Pirmohamed & Park, 2003). It is an antagonist of vitamin K, which inhibits the conversion of oxidized vitamin K epoxide into its reduced form, which is required for gamma carboxylation of the coagulation factors and anticoagulant proteins C and S (Juurlink, 2007). The independent pharmacological action of KT on a separate limb of the hemostatic mechanism from that which is affected by WR raises the potential of a clinically important interaction occurring when WR and KT are co-administered. Since kidneys are among the target organs affected by these drugs, the present investigation was undertaken to investigate the co-administration adverse effects of KT and WR, paying particular attention to prospective nephrotoxicity accompanied with such overlapped administration.
Thirty-two adult male Wistar albino rats weighing 150–180 g were purchased from the animal house colony in Research Institute of Ophthalmology (Giza, Egypt), kept in a controlled environment, and allowed slandered laboratory diet and drinking water ad libitum throughout the experimental period in accordance with the guidelines of the Ethical Committee.
The rats were divided into four groups of eight animals each. Group 1 was orally administered with distilled water and served as the control group. Group 2 served as the ketorolac (KT) group which was daily injected intramuscularly with ketorolac tromethamine (3 mg/kg/day) (Buckley, Davidson, & Das, 1993). Group 3 served as the warfarin (WR) group which was orally administered with racemic warfarin (0.3 mg/kg/day) (Ozcan et al., 2012). Group 4, the combined group (KT/WR), animals received an oral administration of WR (0.3 mg/kg/day) followed by an intramuscular injection of KT (3 mg/kg/day). At the end of the experiment, after six consecutive days of daily treatment, all animals were sacrificed by cervical dislocation and their blood and tissue samples were collected.
Sera were separated and stored in aliquots at − 70 °C till used for estimation of serum urea and creatinine levels. Then, the abdomen was opened and the kidneys were removed, washed three times in ice cold saline, and blotted individually on ash-free filter paper.
Preparation of tissue homogenates for biochemical analysis
Specimens from each kidney tissue were separated into two parts. Each piece was weighted and homogenized separately with a tissue homogenizer. One part was homogenized in phosphate buffer saline (PBS) 50 mM, pH 7.4, for the estimation of total antioxidant capacity (TAC) and reduced glutathione (GSH) level; the second was homogenized in potassium phosphate buffer 10 mM, pH 7.4, for the estimation of malondialdyhed (MDA). The crude tissue homogenate was centrifuged at 10,000 rpm for 15 min in cold centrifuge, and the resultant supernatant was used for the different estimations.
The level of clinical biochemistry for urea and creatinine was measured using commercially available kits according to the manufacturer’s instructions (SPECTRUM Diagnostics kit was procured from the Egyptian Company for Biotechnology (S.A.E), Obour city industrial area, block 20008 piece 19 A. Cairo, Egypt).
Measurement of tissue malondialdehyde
The extent of lipid peroxidation was monitored through measuring the level of MDA using commercial kits as described by Ohkawa, Ohishi, and Yagi (1979). The method depends on the interaction of thiobarbituric acid with MDA in acidic medium at a temperature of 95 °C to form thiobarbituric acid reactive product, and the absorbance of the resultant pink product was measured at 534 nm.
Measurement of tissue reduced glutathione
GSH concentration was determined by the method described by Beutler, Duron, and Kelly (1963) in tissue homogenate. The method was based on the reduction of 5,5′ dithiobis-2-nitrobenzoic acid with GSH to produce a yellow compound. The reduced chromogen was directly proportional to GSH concentration, and its absorbance was measured at 412 nm. A parallel standard was also maintained.
Measurement of tissue total antioxidant capacity
The TAC was determined using commercial kits purchased from Biodiagnostic based on the method described by Koracevic, Koracevic, Djordjevic, Andrejevic, and Cosic (2001). The determination of the antioxidative capacity was performed by the reaction of antioxidants in the sample with a defined amount of exogenously provided hydrogen peroxide (H2O2). The antioxidants in the sample eliminated a certain amount of the provided hydrogen peroxide. The residual H2O2 was determined colorimetrically by an enzymatic reaction which involves the conversion of 3,5 dichloro-2-hydroxy benzensulphonate to a colored product. The color was measured spectrophotometrically at 505 nm. Protein content in tissue homogenate was measured according to the method of Lowry, Rosebrough, Farr, and Randall (1951).
Electron microscopic preparations
Ultrastructural studies were done on the renal cortical tissue of rats which were sacrificed after 6 days of treatment. Approximately, 1 mm3 pieces of kidney cortex were immediately fixed in 3% phosphate-buffered glutaraldehyde (pH 7.3) at room temperature for 2 h, and then post-fixed in 1% buffered osmium tetroxide for 1–2 h at 4 °C, dehydrated in ascending grade of ethanol, and embedded in Epon. Semi-thin sections (1 μm) were stained with toluidine blue and examined with a light microscope. Ultrathin sections (70 nm) were obtained from the selected blocks, mounted on copper grads, and stained with uranyl acetate and lead citrate. The stained grads were then examined by a JEOL-JEM.1400 transmission electron microscope.
Data obtained from specimens were analyzed by using the one-way ANOVA. Statistical analyses were performed using statistical package program SPSS 15.0 (IBM Corp., Armonk, NY), and statistical significance was determined when p values were less than 0.05.
As compared to the control group, Table 1 shows the variable degrees of alteration in kidney function and oxidative stress parameters of treated rats. Urea was significantly increased in KT/WR treated rats; however, creatinine levels showed a significant decrease in both WR and KT/WR groups. As regards to the oxidative stress parameters, MDA showed a significant increase of renal tissue level in both WR and KT/WR treated rats; however, the GSH level showed a significant decrease in rats which received WR. Besides, TAC level records a significant decrease in KT, WR, and KT/WR treated groups.
The cortical parenchyma of the rat kidney contained renal corpuscles, blood vessels, and tubules. Light microscopic investigation showed the normal renal corpuscles as dense, rounded glomeruli surrounded by narrow Bowman’s spaces, and different tubules vary in their diameter and staining affinities; these are proximal convoluted tubule (PCT), distal convoluted tubule (DCT), and collecting tubule (CT) (Fig. 1 a). In all treated groups (KT, WR, and KT/ WR) densely stained, hypertrophic glomeruli were seen surrounded by smaller Bowman’s spaces filled with casts (Fig. 1b–d). Besides, congested blood vessels and varying degrees of tubular degeneration were also seen in KT group (Fig. 1b). Sections of co-administrative KT/WR group showed multiple necrotic foci in kidney tubules (Fig. 1d). Compared to the control sections (Fig. 2a–d), electron microscopic investigation localized vascular congestion and severe vacuolation in the glomerulus (Fig. 3a) and tubular cells of KT group (Fig. 3b–d). PCT appeared with damaged mitochondria and fragmented microvilli and basal enfolding and many lysosomes (Fig. 3b). Ultrathin sections of the WR group showed severe glomerular and tubular vacuolation (Fig. 4a–d), damage and disorganization of mitochondria, and basal enfolding (Fig. 4a, c). Clear cells of the CT appeared with fragmented cellular membrane (Fig. 4d). The co-administrative group (KT/WR) revealed dilated blood capillaries and damaged plasma membranes of renal glomeruli (Fig. 5a). Figure 5b and c showed the severe vacuolation and degeneration of PCT and DCT lining cells. Figure 5d showed damaged and disorganized mitochondria, many lysosomes, and fragmented basal enfolding of the tubular cells.
Ketorolac is considered a potent analgesic with moderate anti-inflammatory effects (Schwier & Tran, 2016), although it has certain harmful effects on vital body organs such as the liver, kidney, and gastrointestinal tract (Aly et al., 2015; Bally et al., 2017; Tomic et al., 2008). During the recent years, an increasing number of studies have been published concerning the nephrotoxic effects of NSAIDs and anticoagulants (Chana et al., 2014; Lanas & Chan, 2017; Ozcan et al., 2012; Sriuttha, Sirichanchuen, & Permsuwan, 2018). The present investigation was constructed to study the co-administrative effect of KT and WR on histological picture and some biochemical parameters of rat kidney.
The current work clearly illustrated that the administration of 3 mg/kg body weight of KT together with 0.3 mg/kg body weight of WR for six consecutive days induced vascular congestion together with variable degrees of degeneration and vacuolation in the glomeruli and tubular cells of all treated groups, being more vigorously attacking the cortical tissues in KT/WR treated rats. The major mechanisms for WR-induced renal toxicity were previously reported as glomerular hemorrhage and tubular dysfunction by obstruction due to RBC casts (Mendonca, Gupta, Valsan, & Tewari, 2017; Ozcan et al., 2012). Similar to Chana et al. (2014) who revealed that KT induced acute kidney injury, another NSAID, diclofenac sodium, was found to induce the congestion in the blood vessels, the degeneration in nephrons, and the increase in the connective tissue in rat kidneys (Khoshvakhti et al., 2015). Thus, the combined treatment of KT and WR may be responsible for the accelerated progressive events of acute kidney injury obtained in the current study.
The serum levels of urea and creatinine are screening tests of renal function; their values remain within the normal range until more than 50% of renal function is lost (Mendonca et al., 2017). At all stages of renal insufficiency, the creatinine is a much more reliable indicator of renal function than the urea because the urea is far more likely to be affected by dietary and physiologic conditions not related to renal function. As kidney function declines, the urinary excretion of urea and creatinine also declines and blood concentration of both increases. However, in acute kidney injury, plasma creatinine and urea levels do not necessarily rise in tandem and the ratio of urea to creatinine may be sometimes increased as urea increased or creatinine decreased (Uchino, Bellomo, & Goldsmith, 2012). Results obtained in the present study revealed mild alterations in the kidney function, reflected as a significant increase in urea of KT/WR-treated rats and a significant decrease in the creatinine level of both WR and KT/WR-treated groups. These altered parameters were in accordance with several reports reflecting a disturbed kidney function (Aly et al., 2015; Hörl, 2010; Kim & Joo, 2007; Pelligand et al., 2015) More recently, Lucas et al. (2018) reported that NSAIDs increase the risk of developing nephrotoxicity and acute tubular necrosis and they recommended that this condition be well evaluated. The authors concluded that NSAIDs, selective and non-selective, directly interfere with renal function due to prostaglandin inhibition, and suggested acute sodium retention, which is the main cause of the overfilling effect due to arterial hypertension and edema (Chana et al., 2014). This edema was clearly localized as severe vacuolation in the kidney tubules of co-administrated group, KT/WR, of the present work. Also, Sabry, Sakr, and Shahin (2014) indicated that treatment with NSAIDs during pregnancy could cause renal dysgenesis in neonates. Cao et al., 2014 reported an acute interstitial nephritis and acute tubule-interstitial disease among older-aged treated Chinese patients. In addition, Ozcan et al. (2012) reported that warfarin treatment resulted in a dose-dependent increase in serum creatinine. This increase following warfarin treatment was greater at 3 and 19 weeks after the ablative surgery. Morphologically, the authors localized the acute tubular injury with RBC and RBC casts in the kidney tubules of treated rats, the picture of which was also visualized in the kidney of KT- and KT/WR-treated rats of the current study. WR as a vitamin K antagonist interferes with vitamin K actions and causes critical adverse side effects on the bone and vascular health (Danziger, 2008; Fusaro et al., 2012, 2015). In 2016, Li et al. indicated that the dose-dependent variations of warfarin are markedly influenced by pharmacokinetic aspects that are determined by genetic and environmental factors. These effects of WR may be responsible for increased renal toxicity when co-administrated with KT in the present study.
As regards the antioxidant status of rat kidney exposed to KT and/or WR, compared to the control animals in the current study, MDA levels increased significantly in WR- and KT/WR-treated rats. However, the levels of GSH and TAC were significantly declined in WR and in all treated groups, respectively. This altered antioxidant status is in accordance with those obtained by other investigators with KT and other NSAID treatments (Adachi et al., 2007; Cantoni et al., 2003; Galar-Martínez et al., 2014). Also, several reports proved that NSAIDs strongly induce oxidative stress with the concomitant production of reactive oxygen species (ROS) (Adachi et al., 2007; Galar-Martínez et al., 2014; Galati, Tafazoli, Sabzevari, Chan, & O'Brien, 2002; Minami et al., 2005). This increased ROS together with the attenuated antioxidant defense system as regarded by decreased GSH and TAC levels of the current study may be responsible not only for the deleterious effects on membrane lipids related to the increased MDA level, but also to the deterioration of proteins and nucleic acids. This in turn leads to renal toxicity, dysfunction, and cellular damage. The present electron microscopic investigation confirmed that KT and/or WR has degenerative effects on rat kidney that could disrupt the normal renal structure and function.
Browne et al. (1999) investigated the pro-oxidant properties of some NSAIDs, including KT in rat hepatic mitochondria. The authors affirmed that these drugs were mostly associated with the disruption of lipid metabolic pathways and mitochondrial function. These obtained data were concomitant with a decrease in ATP production, increased ROS and elevated oxidative stress (Grosch, Tegeder, Niederberger, Brautigam, & Geisslinger, 2001; Hickey, Raje, Reid, Gross, & Ray, 2001; Maity et al., 2008, 2009; Mingatto, Santos, Uyemura, Jordani, & Curti, 1996; Pal et al., 2010, 2012), and induced renal injury. On the other hand, warfarin via direct or indirect effects (vitamin K-dependent proteins) may affect the glomerular filtration barrier, which results in glomerular hemorrhage with subsequent occlusive red blood cell cast formation and acute kidney injury. Based on this hypothesis, oxidative stress exerted by KT/WR treatment may play a significant role in both glomerular filtration barrier damage and acute tubular injury of rat kidney obtained in the present study.
Ware et al. (2013) explained the following mechanisms of increased oxidative stress in an animal model of warfarin-related nephropathy. First, free hemoglobin released by RBC in the tubular lumen affects tubular epithelial cells by generating reactive oxygen species and increasing lipid peroxidation. Second, free hemoglobin incorporates into the tubular epithelial cells via several surface receptors, such as megalin-cubilin receptors (Tracz, Alam, & Nath, 2007). Intracellularly, free hemoglobin activates caspases and induces apoptosis (Homsi, Janino, & de Faria, 2006). Third, the intracellular hemoglobin dissociates into globin and heme, while the latter is also a potent oxidant and activates pro-inflammatory pathways (Tsiftsoglou, Tsamadou, & Papadopoulou, 2006).
From the present biochemical and histopathological data, it can be concluded that the combined treatment of anti-inflammatory and anticoagulant drugs induced renal injury and histological alterations through the suppression of the antioxidant defense system and enhancement of oxidative stress. Thus, we recommend that the use of these combined drugs must be restricted, especially in the elderly who suffer from renal diseases and other comorbidities.
Distal convoluted tubule
Non-steroidal anti-inflammatory drugs
Phosphate buffer saline
Proximal convoluted tubule
Red blood cell
Reactive oxygen species
Total antioxidant capacity
Adachi, M., Sakamoto, H., Kawamura, R., Wang, W., Imai, K., & Shinomura, Y. (2007). Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histology and Histopathology, 22(4–6), 437–442.
Aly, S., Mahmoud, M. F., Hassan, S. H. M., & Fahmy, A. (2015). Evaluation of the analgesic activity and safety of ketorolac in whole body fractionated gamma irradiated animals. Future Journal of Pharmaceutical Sciences, 1(1), 8–15.
Bally, M., Dendukuri, N., Rich, B., Nadeau, L., Helin-Salmivaara, A., Garbe, E., & Brophy, J. M. (2017). Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. British Medical Journal, 357, j1909.
Beutler, E., Duron, O., & Kelly, B. M. (1963). Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine, 61, 882–888.
Brodsky, S. V., Collins, M., Park, E., Rovin, B. H., Satoskar, A. A., Nadasdy, G., … Hebert, L. A. (2010). Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clinical Practice, 115, c142–c146.
Brodsky, S. V., Nadasdy, T., Rovin, B. H., Satoskar, A. A., Nadasdy, G. M., Wu, H. M., … Hebert, L. A. (2011). Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney International, 80, 181–189.
Brodsky, S. V., Satoskar, A., Chen, J., Nadasdy, G., Eagen, J. W., Hamirani, M., … Nadasdy, T. (2009). Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: A report of 9 cases. American Journal of Kidney Diseases, 54, 1121–1126.
Browne, G. S., Nelson, C., Nguyen, T., Ellis, B. A., Day, R. O., & Williams, K. M. (1999). Stereoselective and substratedependent inhibition of hepatic mitochondria betaoxidation and oxidative phosphorylation by the nonsteroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and ketorolac. Biochemical Pharmacology, 57(7), 837–844.
Buckley, R. C., Davidson, S. F., & Das, S. A. (1993). Effects of ketorolac tromethamine (ToradolR) on a functional model of microvascular thrombosis. British Journal of Plasric Surgery, 46, 296–299.
Cantoni, L., Valaperta, R., Ponsoda, X., Castell, J. V., Barelli, D., Rizzardini, M., et al. (2003). Induction of hepatic hemoxygenase-1 by diclofenac in rodents: Role of oxidative stress and cytochrome P-450 activity. Hepatology, 38, 776–783.
Cao, Y. L., Tian, Z. G., Wang, F., Li, W. G., Cheng, D. Y., Yang, Y. F., & Gao, H. M. (2014). Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patients. World Journal of Gastroenterology, 20(38), 13956–13965.
Chana, J., Bajnatha, A., Fromkina, B., Hainea, D., Paixaoa, R., Sandya, D., … Brauna, M. (2014). Ketorolac prescribing practices in an acute care hospital and the incidence of acute renal failure. World Journal of Nephrology and Urology, 3(3), 113–117.
Danziger, J. (2008). Vitamin K-dependent proteins, warfarin, and vascular calcification. Clinical Journal of American Society Nephrology, 3, 1504–1510.
Eriksson, N., & Wadelius, M. (2012). Prediction of warfarin dose: Why, when and how? Pharmacogenomics, 13, 429–440.
Fusaro, M., Noale, M., Viola, V., Galli, F., Tripepi, G., Vajente, N., et al. (2012). Vitamin K, vertebral fractures, vascular calcifications, and mortality: Vitamin K Italian (VIKI) dialysis study. Journal of Bone and Mineral Research, 27, 2271–2278.
Fusaro, M., Tripepi, G., Noale, M., Plebani, M., Zaninotto, M., Piccoli, A., et al. (2015). Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Current Vascular Pharmacology, 13, 248–258.
Galar-Martínez, M., Garcıa-Medina, S., Gomez-Olivan, L. M., Perez-Coyotl, I., MendozaMonroy, D. J., & Arrazola-Morgain, R. E. (2014). Oxidative stress and genotoxicity induced by ketorolac on the common carp Cyprinus carpio. Environmental Toxicology, 31, 1035–1043.
Galati, G., Tafazoli, S., Sabzevari, O., Chan, T. S., & O'Brien, P. J. (2002). Idiosyncratic NSAID drug induced oxidative stress. Chemico-Biological Interactions, 142(1–2), 25–41.
Grosch, S., Tegeder, I., Niederberger, E., Brautigam, L., & Geisslinger, G. (2001). COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB Journal, 15, 2742–2744.
Hickey, E. J., Raje, R. R., Reid, V. E., Gross, S. M., & Ray, S. D. (2001). Diclofenac- induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radical Biology and Medicine, 31(26), 139–152.
Homsi, E., Janino, P., & de Faria, J. B. (2006). Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney International, 69, 1385–1392.
Hörl, W. H. (2010). Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals (Basel), 3, 2291–2321.
Ilic, S., Drmic, D., Franjic, S., Kolenc, D., Coric, M., Brcic, L., et al. (2011). Pentadeca peptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Life Science, 88(11–12), 535–542.
Juurlink, D. N. (2007). Drug interactions with warfarin: What clinicians need to know. Canadian Medical Association Journal, 177(4), 369–371.
Khoshvakhti, H., Yurt, K. K., Altunkaynak, B. Z., Türkmen, A. P., Elibol, E., Aydın, I., … Kaplan, S. (2015). Effects of melatonin on diclofenac sodium treated rat kidney: A stereological and histopathological study. Renal Failure, 37(8), 1379–1383.
Kim, S., & Joo, K. W. (2007). Electrolyte and acid-base disturbances associated with non-steroidal anti-inflammatory drugs. Electrolyte Blood Press, 5, 116–125.
Koracevic, D., Koracevic, G., Djordjevic, V., Andrejevic, S., & Cosic, V. (2001). Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology, 54, 356–361.
Lanas, A., & Chan, F. K. L. (2017). Peptic ulcer disease. Lancet., 390(10094), 613–624.
Li, H., Wang, Y., Fan, R., Lv, H., Sun, H., Xie, H., … Xia, Z. (2016). The effects of ferulic acid on the pharmacokinetics of warfarin in rats after biliary drainage. Development and Therapy, 10, 2173–2180.
Liu, Y., Jeong, H., Takahashi, H., Drozda, K., Patel, S. R., Shapiro, N. L., et al. (2012). Decreased warfarin clearance associated with the CYP2C9 R15OH (*8) polymorphism. Clinical Pharmacology and Therapeutics, 269, 1–6.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
Lucas, G. N. C., Leitão, A. C. C., Alencar, R. L., Xavier, R. M. F., Daher, E. F., & Silva Junior, G. B. D. (2018). Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. Jornal Brasileiro de Nefrologia, 12, 1139–1146.
Maity, P., Bindu, S., Choubey, V., Alam, A., Mitra, K., Goyal, M., … Bandyopadhyay, U. (2008). Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fasmediated death pathways with concurrent induction of mucosal cell renewal. Journal of Biological Chemistry, 283, 14391–14401.
Maity, P., Bindu, S., Dey, S., Goyal, M., Alam, A., Pal, C., … Bandyopadhyay, U. (2009). Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa. A novel role of mitochondrial aconitase oxidation. Journal of Biological Chemistry, 284, 3058–3068.
Mendonca, S., Gupta, D., Valsan, A., & Tewari, R. (2017). Warfarin related acute kidney injury: A case report. Indian Journal of Nephrology, 27(1), 78–80.
Minami, T., Adachi, M., Kawamura, R., Zhang, Y., Shinomura, Y., & Imai, K. (2005). Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity. Clinical Cancer Research, 11, 5248–5256.
Mingatto, F. E., Santos, A. C., Uyemura, S. A., Jordani, M. C., & Curti, C. (1996). In vitro interaction of nonsteroidal antiinflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: Respiration and ATP synthesis. Archives of Biochemistry and Biophysics, 334, 303–308.
Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95, 351–335.
Ozcan, A., Ware, K., Calomeni, E., Nadasdy, T., Forbes, R., Satoskar, A. A., … Brodsky, S. V. (2012). 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. American Journal of Nephrology, 35, 356–364.
Pal, C., Bindu, S., Dey, S., Alam, A., Goya, M., Iqbal, M. S., … Bandyopadhyay, U. (2010). Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis. Free Radical Biology and Medicine, 49(2), 258–267.
Pal, C., Bindu, S., Dey, S., Alam, A., Goyal, M., Iqbal, M. S., … Bandyopadhyay, U. (2012). Tryptamine-gallic acid hybrid prevents non-steroidal anti-inflammatory drug-induced gastropathy, correction of mitochondrial dysfunction and inhibition of apoptosis in gastric mucosal cells. Journal of Biological Chemistry, 287(5), 3495–3509.
Pelligand, L., Suemanotham, N., King, J. N., Seewald, W., Syme, H., Smith, K., et al. (2015). Effect of cyclooxygenase (COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney. BMC Veterinary Research, 11, 296.
Pirmohamed, M., & Park, B. K. (2003). Adverse drug reactions: Back to the future. Journal of Clinical Pharmacology, 55, 486–492.
Sabry, S. A., Sakr, S. M., & Shahin, M. A. (2014). Histological and ultrastructural studies on the effect of diclofenac sodium on the renal cortex of fetuses of albino mice. Global Journal of Pharmacology, 8, 369–377.
Schwier, N., & Tran, N. (2016). Non-steroidal anti-inflammatory drugs and aspirin therapy for the treatment of acute and recurrent idiopathic pericarditis. Pharmaceuticals, 9(2), 2–18.
Sriuttha, P., Sirichanchuen, B., & Permsuwan, U. (2018). Hepatotoxicity of nonsteroidal anti-inflammatory drugs: A systematic review of randomized controlled trials. International Journal of Hepatology, 2018, 1–13. 5253623.
Tomic, Z., Milijasevic, B., Sabo, A., Dusan, L., Jakovljevic, V., Mikov, M., … Vasovic, V. (2008). Diclofenac and ketoprofen liver toxicity in rat. European Journal of Drug Metabolism and Pharmacokinetics, 33(4), 253–260.
Tracz, M. J., Alam, J., & Nath, K. A. (2007). Physiology and pathophysiology of heme: Implications for kidney disease. Journal of the American Society of Nephrology, 18, 414–420.
Tsiftsoglou, A. S., Tsamadou, A. I., & Papadopoulou, L. C. (2006). Heme as key regulator of major mammalian cellular functions: Molecular, cellular, and pharmacological aspects. Pharmacology & Therapeutics, 111, 327–345.
Uchino, S., Bellomo, R., & Goldsmith, D. (2012). The meaning of the blood urea nitrogen/creatinine ratio in acute kidney injury. Clinical Kidney Journal, 5(2), 187–191.
Utzeri, E., & Usai, P. (2017). Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World Journal of Gastroenterology, 23(22), 3954–3963.
Ware, K., Qamri, Z., Ozcan, A., Satoskar, A. A., Nadasdy, G., Rovin, B. H., … Brodsky, S. V. (2013). N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. American Journal of physiology-Renal physiology, 304(12), F1421–F1427.
There is no acknowledgment.
Availability of data and materials
The data are available from the authors.
Ethics approval and consent to participate
Animals were treated in accordance with the guidelines of the Ethical Committee for animal care of the “Faculty of Science–Cairo University” with approval number CU-I-F-70/18.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Othman, A.I., Abdel-Ghaffar, A. & Mahmoud, A.M. Ketorolac- and warfarin-induced renal toxicity: ultrastructural and biochemical study. JoBAZ 80, 36 (2019). https://doi.org/10.1186/s41936-019-0106-2
- Oxidative stress